Pular para o conteúdo principal
Ranking Invest

TXG - 10x Genomics, Inc.

Segmento: Healthcare10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Análise Ranking Invest

Valor de Mercado
-13,38%
$ 9.85 Bi
IVR
0.03Índice proprietário de comparação relativa: 0,03.
IVR2
-0.05Leitura proprietária complementar: -5%.
MLL
-0.05Leitura proprietária complementar: -5%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 825.55 Mi

L4T

-$ 75.13 Mi

MM4T

-12.26%

Indicadores Básicos

ROE

-9.10%

Índices de Previsibilidade

Receita Líquida

C0.06

Lucro

C0.44

Margem

C0.43

Índices de Tendência

Receita Líquida

C4.12

Lucro

B6.31

Margem

B6.77

Índices de Endividamento

DIV/PAT

0.00

DIV/L4T

0.00

Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.